Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2014, Article ID 412815, 10 pages
http://dx.doi.org/10.1155/2014/412815
Research Article

Neutralization by Insulin of the Hypertensive Effect of Dermcidin Isoform 2: An Environmentally Induced Diabetogenic and Hypertensive Protein

1Sinha Institute of Medical Science and Technology, 288 Kendua Main Road, Garia 700 084, India
2Gandhi Memorial Hospital, Kalyani, West Bengal 741245, India
3RR&D Center of Excellence, James J. Peters VA Medical Center, 130 W. Kingsbridge Road, Bronx, NY 10468, USA

Received 8 October 2013; Accepted 17 December 2013; Published 4 February 2014

Academic Editor: Michael S. Wolin

Copyright © 2014 Rajeshwary Ghosh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. H. Messerli, B. Williams, and E. Ritz, “Essential hypertension,” The Lancet, vol. 370, no. 9587, pp. 591–603, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. S. B. Harrap, “Where are all the blood-pressure genes?” The Lancet, vol. 361, no. 9375, pp. 2149–2151, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. A. Province, S. L. R. Kardia, K. Ranade et al., “A meta-analysis of genome-wide linkage scans for hypertension: the National Heart, Lung and Blood Institute Family Blood Pressure Program,” The American Journal of Hypertension, vol. 16, no. 2, pp. 144–147, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. I. J. Perry, P. H. Whincup, and A. G. Shaper, “Environmental factors in the development of essential hypertension,” British Medical Bulletin, vol. 50, no. 2, pp. 246–259, 1994. View at Google Scholar · View at Scopus
  5. T. G. Pickering, “The effects of environmental and lifestyle factors on blood pressure and the intermediary role of the sympathetic nervous system,” Journal of Human Hypertension, vol. 11, supplement 1, pp. S9–S18, 1997. View at Google Scholar · View at Scopus
  6. R. Ghosh, S. K. Karmohapatra, M. Bhattacharyya, R. Bhattacharya, G. Bhattacharya, and A. K. Sinha, “The appearance of dermcidin isoform 2, a novel platelet aggregating agent in the circulation in acute myocardial infarction that inhibits insulin synthesis and the restoration by acetyl salicylic acid of its effects,” Journal of Thrombosis and Thrombolysis, vol. 31, no. 1, pp. 13–21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Ghosh, U. K. Maji, R. Bhattacharya, and A. K. Sinha, “The role of dermcidin isoform 2, a two faceted atherosclerotic risk factor for coronary artery disease and the effect of acetyl salicylic acid on it,” Thrombosis, vol. 2012, Article ID 987932, 9 pages, 2012. View at Publisher · View at Google Scholar
  8. R. Ghosh, P. Jana, and A. K. Sinha, “The control of hyperglycemia in alloxan treated diabetic mice through the stimulation of hepatic insulin synthesis due to the production of nitric oxide,” Experimental and Clinical Endocrinology and Diabetes, vol. 120, no. 3, pp. 145–151, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. I. H. de Boer, B. Kestenbaum, T. C. Rue et al., “Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus,” Archives of Internal Medicine, vol. 168, no. 17, pp. 1867–1873, 2008. View at Google Scholar
  10. J. R. Sowers, P. R. Standley, J. L. Ram, S. Jacober, L. Simpson, and K. Rose, “Hyperinsulinemia, insulin resistance, and hyperglycemia: contributing factors in the pathogenesis of hypertension and atherosclerosis,” The American Journal of Hypertension, vol. 6, no. 7, pp. 260S–270S, 1993. View at Google Scholar · View at Scopus
  11. S. Chakraborty, G. A. Khan, S. K. Karmohapatra, R. Bhattacharya, G. Bhattacharya, and A. K. Sinha, “Purification and mechanism of action of “cortexin”, a novel antihypertensive protein hormone from kidney and its role in essential hypertension in men,” Journal of the American Society of Hypertension, vol. 3, no. 2, pp. 119–132, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. I. Furman, S. E. Benoit, M. R. Barnard et al., “Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease,” Journal of the American College of Cardiology, vol. 31, no. 2, pp. 352–358, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Fuster, J. Badimon, J. H. Chesebro, and J. T. Fallon, “Plaque rupture, thrombosis, and therapeutic implications,” Haemostasis, vol. 26, no. 4, pp. 269–284, 1996. View at Google Scholar · View at Scopus
  14. K. Chakraborty and A. K. Sinha, “The role of insulin as an antithrombotic humoral factor,” BioEssays, vol. 26, no. 1, pp. 91–98, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. A. K. Sinha, S. Bhattacharya, K. Acharya, and S. Mazumder, “Stimulation of nitric oxide synthesis and protective role of insulin in acute thrombosis in vivo,” Life Sciences, vol. 65, no. 25, pp. 2687–2696, 1999. View at Google Scholar · View at Scopus
  16. K. Chakraborty, G. A. Khan, P. Banerjee, U. Ray, and A. K. Sinha, “Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin,” Platelets, vol. 14, no. 7-8, pp. 421–427, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Bhattacharyya, S. K. Karmohapatra, G. Bhattacharya, R. Bhattacharya, and A. K. Sinha, “The role of leucocytes in the acetyl salicylic acid (aspirin) induced nitric oxide synthesis in the production of interferon-α, a potent inhibitor of platelet aggregation and a thrombolytic agent,” Journal of Thrombosis and Thrombolysis, vol. 28, no. 2, pp. 173–184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Matsudaira, “Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes,” Journal of Biological Chemistry, vol. 262, no. 21, pp. 10035–10038, 1987. View at Google Scholar · View at Scopus
  19. S. K. Karmohapatra, K. Chakraborty, N. N. Kahn, and A. K. Sinha, “The role of nitric oxide in aspirin induced thrombolysis in vitro and the purification of aspirin activated nitric oxide synthase from human blood platelets,” The American Journal of Hematology, vol. 82, no. 11, pp. 986–995, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Knip and H. K. Åkerblom, “Environmental factors in the pathogenesis of type 1 diabetes mellitus,” Experimental and Clinical Endocrinology and Diabetes, vol. 107, supplement 3, pp. S93–S100, 1999. View at Google Scholar · View at Scopus
  21. H. Yanai, Y. Tomono, K. Ito, N. Furutani, H. Yoshida, and N. Tada, “The underlying mechanisms for development of hypertension in the metabolic syndrome,” Nutrition Journal, vol. 7, no. 1, article 10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. R. S. Surwit, M. S. Schneider, and M. N. Feinglos, “Stress and diabetes mellitus,” Diabetes Care, vol. 15, no. 10, pp. 1413–1422, 1992. View at Google Scholar · View at Scopus
  23. R. Ghosh, R. Bhattacharya, G. Bhattacharya, and A. K. Sinha, “The control of stress induced type I diabetes mellitus in humans through the hepatic synthesis of insulin by the stimulation of nitric oxide production,” International Journal of Biomedical Science, vol. 8, no. 3, pp. 171–182, 2012. View at Google Scholar
  24. N. N. Kahn, K. Acharya, S. Bhattacharya et al., “Nitric oxide: the 'second messenger' of insulin,” IUBMB Life, vol. 49, no. 5, pp. 441–450, 2000. View at Google Scholar · View at Scopus
  25. G. Wilcox, “Insulin and insulin resistance,” Clinical Biochemist Reviews, vol. 26, no. 2, pp. 19–39, 2005. View at Google Scholar
  26. S. Bank, R. Ghosh, P. Jana, S. Bhattacharya, and A. K. Sinha, “The diagnosis of high altitude illness by the determination of plasma dermcidin isoform 2 levels by enzyme linked immunosorbent assay,” Clinical Laboratory. In press.
  27. R. Ghosh, S. K. Karmohapatra, G. Bhattacharya, and A. Kumar Sinha, “The glucose-induced synthesis of insulin in liver,” Endocrine, vol. 38, no. 2, pp. 294–302, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Ghosh, M. Bhattacharyya, G. Khan et al., “Diagnosis of essential hypertension in humans by the determination of plasma renal cortexin using enzyme-linked immunosorbent assay,” vol. 59, no. 5-6, pp. 475–481, 20132013. View at Publisher · View at Google Scholar
  29. U. K. Maji, R. Ghosh, S. Mazumder, R. Bhattacharya, M. Bhattacharyya, and A. K. Sinha, “Control of elevated blood pressures by acetyl salicylic acid (Aspirin) in randomized patients diagnosed to be hypertensive at presentation,” in Aspirin: Therapeutic Uses, Adverse Effects and Pharmacokinetics, D. M. Demir, Ed., pp. 107–122, Nova Publishers, 2011. View at Google Scholar
  30. J. R. Sowers, M. Epstein, and E. D. Frohlich, “Diabetes, hypertension, and cardiovascular disease an update,” Hypertension, vol. 37, no. 4, pp. 1053–1059, 2001. View at Google Scholar · View at Scopus
  31. C. H. Hennekens, M. L. Dyken, and V. Fuster, “Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American heart association,” Circulation, vol. 96, no. 8, pp. 2751–2753, 1997. View at Google Scholar · View at Scopus
  32. J.-W. Yoon and H.-S. Jun, “Autoimmune destruction of pancreatic β cells,” The American Journal of Therapeutics, vol. 12, no. 6, pp. 580–591, 2005. View at Publisher · View at Google Scholar · View at Scopus